PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
£79.00
Buy BPC-157 + TB500 Peptide Bundle in UAE – In Stock & Ready to Ship
BPC-157 and TB500 bundle is a widely researched peptide combination known for its role in tissue repair, cellular recovery and regenerative studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing peptide bundles for serious work.
For research use only. Not intended for human or veterinary use.
BPC-157 and TB-500 is the most widely researched dual tissue repair peptide stack available to laboratories in the UAE — combining a gastric pentadecapeptide with proven multi-tissue repair properties alongside the body’s primary actin-regulating repair neuropeptide to produce a complementary, mechanistically distinct dual-pathway approach to studying tissue regeneration, wound healing, angiogenesis, and cytoprotection that neither compound achieves alone. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade BPC-157 and TB-500 as a convenient bundle with fast international dispatch and full batch documentation included for each compound.
✅ ≥99% Purity Each — HPLC & Mass Spectrometry Verified
✅ Batch-Specific Certificate of Analysis (CoA) for Each Peptide
✅ Sterile Lyophilised Powder | GMP Manufactured
✅ Fast International Dispatch to UAE & GCC
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide — a 15 amino acid sequence — derived from a protective protein found in gastric juice. Unlike many research peptides derived from systemic hormones or growth factors, BPC-157 originates from the gastrointestinal system, which has informed its particularly strong research profile in GI tract biology alongside its broader multi-tissue repair applications.
BPC-157 operates through multiple overlapping mechanisms simultaneously — it promotes angiogenesis through upregulation of VEGF and other angiogenic mediators, activates growth hormone receptor signalling in peripheral tissues, modulates nitric oxide (NO) synthesis, and influences tendon fibroblast biology through FAK and paxillin signalling pathways. This multi-pathway activity profile is what makes BPC-157 such a broadly applicable repair research tool — its effects are not limited to a single receptor system or tissue type but emerge from simultaneous engagement of several fundamental repair and regeneration mechanisms.
Research has examined BPC-157 across an exceptionally wide range of tissue types including gastrointestinal mucosa, tendons and ligaments, skeletal muscle, bone, neural tissue, and cardiac tissue — establishing it as one of the most versatile repair peptides in pre-clinical research. It is orally stable — an unusual property for a peptide — which has made it a useful research tool for studying gut biology through oral administration models.
TB-500 is the synthetic form of Thymosin Beta-4 (Tβ4) — a naturally occurring 43 amino acid peptide found in virtually every cell in the body, present at particularly high concentrations in platelets, wound fluid, and tissues undergoing active repair. Its primary molecular function is sequestering G-actin — the monomeric form of actin — thereby regulating the dynamic balance between G-actin and filamentous F-actin that governs cell migration, morphology, and cytoskeletal organisation.
Since cell migration is the foundational cellular mechanism underlying wound closure, immune cell trafficking, and tissue repair, TB-500’s regulation of actin polymerisation dynamics places it at the mechanistic centre of multiple simultaneous repair processes. Beyond actin regulation, research has characterised TB-500 as a pleiotropic repair peptide with additional anti-inflammatory, angiogenic, and stem cell activating properties — making it one of the most multifunctional endogenous repair peptides studied in regenerative biology.
TB-500’s research profile spans cardiac tissue protection, neural repair, wound healing acceleration, skeletal muscle repair, and corneal biology — reflecting the ubiquitous importance of actin dynamics and cell migration across virtually every tissue repair process in mammalian biology.
The research rationale for combining BPC-157 and TB-500 is mechanistically well-founded — the two compounds approach tissue repair through complementary and largely non-overlapping molecular pathways that are naturally designed to work in concert during the repair process:
Complementary Mechanisms: BPC-157 operates primarily through angiogenesis promotion, growth hormone receptor signalling, nitric oxide modulation, and tendon fibroblast pathway activation. TB-500 operates primarily through actin dynamics regulation, cell migration enhancement, and its own independent anti-inflammatory and angiogenic signalling. Together they engage repair biology from multiple distinct angles simultaneously.
Angiogenesis Synergy: Both compounds independently promote new blood vessel formation through different mechanisms — BPC-157 through VEGF upregulation and TB-500 through its own angiogenic signalling pathways. Research examining both compounds together explores whether this dual angiogenic input produces additive or synergistic vascularisation effects in repair tissue models.
Repair Phase Coverage: BPC-157’s strong GI and connective tissue repair profile complements TB-500’s strength in systemic cell migration, cardiac protection, and neural repair — together providing broader tissue coverage than either compound alone across the full spectrum of repair biology research.
Anti-Inflammatory Complementarity: Both compounds independently modulate inflammatory signalling through different pathways — with BPC-157’s NO-mediated and TB-500’s actin/cytoskeletal anti-inflammatory mechanisms providing complementary inflammatory resolution research tools.
Research Protocol Practicality: The combination of two well-characterised, extensively studied repair peptides with distinct mechanisms provides researchers with a dual-pathway repair stimulation model that is well-supported by independent literature bases for each compound — enabling mechanistic dissection of combined repair responses.
BPC-157 Research Applications: Studies have used BPC-157 to examine gastrointestinal mucosal repair and protection, tendon and ligament healing mechanisms, skeletal muscle repair biology, bone healing pathway studies, neural tissue protection and repair, and angiogenesis induction in ischaemic tissue models. Its oral stability has made it particularly valuable for GI biology research through oral administration protocols. Research has also examined its modulation of dopamine and serotonin systems — revealing a neurobiological dimension beyond its repair applications.
TB-500 Research Applications: Studies have used TB-500 to examine actin polymerisation dynamics and cell migration biology, cardiac tissue protection and repair following ischaemic injury, wound healing acceleration in dermal and corneal models, neural tissue repair and axonal regeneration pathway studies, and skeletal muscle repair alongside satellite cell interactions. Its systemic distribution and broad tissue protective profile have made it a referenced research tool across multiple repair biology disciplines simultaneously.
Combined Protocol Research: Studies examining both compounds together have explored how dual-pathway tissue repair stimulation influences angiogenesis, inflammatory resolution, connective tissue remodelling, and overall repair outcomes across multiple tissue types — providing a more comprehensive picture of repair biology than single-compound studies allow.
All applications listed are research-based only. Neither compound is approved for human therapeutic use.
BPC-157 Research Findings: Pre-clinical research has characterised BPC-157’s protective and repair-promoting effects across GI mucosa, tendons, muscle, bone, and neural tissue — with studies consistently documenting accelerated healing parameters, reduced inflammatory markers, and promoted angiogenesis across multiple experimental injury models. Its modulation of growth hormone receptors in peripheral tissue has been proposed as a central mechanism underlying its broad tissue repair activity, and its unusual oral stability has made it a uniquely versatile research tool for studying systemic repair responses through non-injectable administration routes.
TB-500 Research Findings: Research has firmly established Thymosin Beta-4’s role as the primary G-actin sequestering peptide in mammalian cells — with studies characterising how its regulation of actin dynamics governs cell migration in wound healing, immune trafficking, and tissue repair. Cardiac research has produced particularly referenced findings — with pre-clinical ischaemia studies documenting cardiomyocyte protection, cardiac stem cell activation, and angiogenesis promotion. Neural and dermal repair research has further established TB-500’s broad tissue-protective profile across multiple model systems.
Combined Findings: The mechanistic complementarity between BPC-157’s multi-pathway repair signalling and TB-500’s actin-centred cell migration and systemic tissue protection has made this combination one of the most studied dual repair peptide protocols in current regenerative biology research — with the two compounds’ distinct mechanisms providing a research framework for studying how simultaneous engagement of multiple repair pathways influences tissue recovery outcomes.
| Combination | Mechanisms | Tissue Coverage | Angiogenesis | Research Basis | Profile |
|---|---|---|---|---|---|
| BPC-157 + TB-500 | Multi-pathway + Actin/cell migration | Broadest | Dual pathway | Extensive independent literature | Most studied combo |
| BPC-157 alone | Multi-pathway repair | GI, tendon, muscle, neural | Strong | Extensively studied | Reference compound |
| TB-500 alone | Actin regulation, cell migration | Cardiac, neural, systemic | Strong | Extensively studied | Reference compound |
| BPC-157 + MGF | Repair + satellite cell activation | Muscle focused | Moderate | Growing | Muscle biology |
| TB-500 + GHK-Cu | Actin + copper remodelling | Dermal focused | Moderate | Well-documented | Wound healing |
| BPC-157 + GHK-Cu | Multi-pathway + remodelling | Connective tissue | Strong | Well-documented | Tissue remodelling |
| Parameter | BPC-157 | TB-500 |
|---|---|---|
| Type | Synthetic pentadecapeptide | Thymosin Beta-4 analogue |
| Chain Length | 15 AA | 43 AA |
| Primary Mechanism | Multi-pathway — VEGF, NO, GHR | Actin sequestration, cell migration |
| Half-Life | Short — systemic distribution | Moderate |
| Purity | ≥99% | ≥99% |
| Verification | HPLC & Mass Spectrometry | HPLC & Mass Spectrometry |
| Form | Lyophilised Powder | Lyophilised Powder |
| Solubility | Sterile / bacteriostatic water | Sterile / bacteriostatic water |
| Storage | -20°C, protect from light | -20°C, protect from light |
| Intended Use | Research only | Research only |
Every bundle order dispatched to the UAE and GCC includes:
Yes. We supply research-grade BPC-157 and TB-500 as a convenient bundle with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include individual documentation for each compound and are packaged to maintain peptide integrity throughout transit. These compounds are supplied strictly for laboratory research use only.
The combination is mechanistically well-suited because the two compounds engage tissue repair biology through largely non-overlapping pathways. BPC-157 works primarily through angiogenesis induction, growth hormone receptor modulation, nitric oxide signalling, and tendon fibroblast pathways. TB-500 works primarily through actin dynamics regulation, cell migration enhancement, and its own independent angiogenic and anti-inflammatory mechanisms. Together they provide simultaneous engagement of multiple fundamental repair mechanisms — creating a more comprehensive dual-pathway repair stimulation model than either compound provides alone.
BPC-157 has its strongest research base in gastrointestinal biology, tendon and connective tissue repair, and broad multi-tissue repair applications — operating through multiple distinct signalling pathways simultaneously. TB-500 has its strongest research base in cell migration biology, cardiac tissue protection, and systemic repair through actin dynamics regulation. BPC-157 is unusual in being orally stable — making it useful for GI research through oral administration models — while TB-500 operates more systemically through its fundamental role in cell motility and migration across all tissue types.
Most peptides are rapidly degraded by gastrointestinal proteases when administered orally — making oral administration impractical for research purposes. BPC-157 is unusual in demonstrating stability against gastric and intestinal enzymatic degradation, enabling meaningful oral administration in pre-clinical research models. This oral stability has made it particularly valuable for studying GI mucosal biology through physiologically relevant oral routes, and has also enabled research into whether orally administered BPC-157 produces systemic effects beyond the GI tract — a mechanistically interesting research question that distinguishes it from most injectable-only repair peptides.
Research examining both compounds in combined protocols has explored how dual-pathway repair stimulation — engaging BPC-157’s multi-pathway signalling alongside TB-500’s actin-centred cell migration and systemic tissue protection — influences angiogenesis, inflammatory resolution, and repair outcomes across multiple tissue injury models. The well-established independent literature bases for each compound provide strong mechanistic context for interpreting combined protocol findings, making this one of the most research-supported dual repair peptide combinations available for studying comprehensive tissue repair biology.
Reconstitute each peptide independently. Allow each vial to reach room temperature before opening. Add sterile or bacteriostatic water slowly down the vial wall of each peptide separately and swirl gently without shaking. Reconstitute each compound to your research protocol’s required concentration. Aliquot and store at -80°C for longer-term use to minimise freeze-thaw degradation and maintain biological activity for both compounds.
Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability and integrity for both compounds throughout transit.
BPC-157 and TB-500 (Thymosin Beta-4) are supplied exclusively for legitimate scientific research conducted within licensed laboratory environments. These products are not intended for human consumption, self-administration, or any therapeutic or veterinary application. They must be handled solely by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. By purchasing, you confirm these compounds will be used exclusively for approved in vitro or pre-clinical research purposes.
Receive News
